F. Bonella (Düsseldorf, Germany), C. McCarthy (Dublin 4, Ireland)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD): an international research prioritisation
H. Bintalib (London, United Kingdom), S. Abbas (London, United Kingdom), K. Warnatz (Freiburg, Germany), J. Hurst (and On Behalf Of The Eglildnet Consortium) (London, United Kingdom)
|    |
Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
F. Lestelle (Lyon, France), M. Nasser (Lyon, France), A. Roux (Suresnes, France), S. Hirschi (Strasbourg, France), L. Wemeau (Lille, France), G. Prévot (Toulouse, France), D. Rotzinger (Lausanne, Switzerland), S. Si-Mohamed (Lyon, France), V. Bunel (Paris, France), E. Gomez (Nancy, France), L. Sohier (Lorient, France), H. Morisse Pradier (Rouen, France), M. Reynaud Gaubert (Marseille, France), A. Gondouin (Besançon, France), R. Lazor (Lausanne, Switzerland), Y. Uzunhan (Bobigny, France), P. Rigaud (Paris, France), M. Colombat (Toulouse, France), C. Beigelman (Lausanne, Switzerland), V. Cottin (Lyon, Switzerland)
| |
Idiopathic chronic obliterative bronchiolitis: a multicentric retrospective cohort
M. Nasser (Lyon, France), Y. Uzunhan (Bobigny, France), S. Hirschi (Strasbourg, France), S. Jouneau (Rennes, France), F. Lebargy (Rennes, France), A. Justet (Rennes, France), C. Taillé (Paris, France), L. Wemeau (Lille, France), V. Valentin (Lille, France), R. Borie (Paris, France), B. Godbert (Metz, France), F. Gagnadoux (Angers, France), L. Guilleminault (Toulouse, France), H. Nunes (Bobigny, France), S. Marchand-Adam (Tours, France), V. Cottin (Lyon, France), M. Nasser (Bron, France)
| |
Specifying pediatric pulmonary hemorrhage: Suggestion of a diagnostic algorithm as guide to disease subcategories
K. Knoflach (Munich, Germany), C. Rapp (Munich, Germany), E. Seidl (Munich, Germany), N. Schwerk (Hannover, Germany), M. Wetzke (Hannover, Germany), J. Carlens (Hannover, Germany), N. Kiper (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), F. Buchvald (Copenhagen, Denmark), A. Madsen Ring (Copenhagen, Denmark), P. Robinson (Farmington, CT, United States of America), M. Griese (Munich, Germany)
| |
Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data
T. Maher (Los Angeles, United States of America), B. Langford (London, United Kingdom), A. Diamantopoulos (London, United Kingdom), K. Rohr (Ingelheim am Rhein, Germany), M. Baldwin (Ingelheim am Rhein, Germany), Y. Inoue (Osaka, Japan)
| |
Prevalence of lymphangioleiomyomatosis in an Irish population and biomarker utility
E. Lynn (Blackrock (Co. Dublin), Ireland), J. Morrow (Blackrock (Co. Dublin), Ireland), A. Fabre (Blackrock (Co. Dublin), Ireland), J. Dodd (Blackrock (Co. Dublin), Ireland), D. Murphy (Blackrock (Co. Dublin), Ireland), M. Keane (Blackrock (Co. Dublin), Ireland), C. Mccarthy (Blackrock (Co. Dublin), Ireland)
| |
Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
L. Jehn (Essen, Germany), J. Wälscher (Essen, Germany), T. Wessendorf (Essen, Germany), E. Livingstone (Essen, Germany), L. Zimmer (Essen, Germany), M. Metzenmacher (Essen, Germany), W. Eberhardt (Essen, Germany), D. Theegarten (Essen, Germany), F. Bonella (Essen, Germany)
| |
A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
C. Lee (Yongin, Republic of Korea), D. Bae (Yongin, Republic of Korea), M. Cho (Yongin, Republic of Korea), S. Shin (Yongin, Republic of Korea), J. Kim (Yongin, Republic of Korea), J. Lee (Yongin, Republic of Korea), S. Kang (Yongin, Republic of Korea), J. Jung (Yongin, Republic of Korea), H. Koo (Yongin, Republic of Korea), J. Park (Yongin, Republic of Korea)
| |
Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis
L. Pandolfi (Pavia, Italy), V. Frangipane (Pavia, Italy), A. Urzainqui (Madrid, Spain), A. Marengo (Paris, France), K. Bohne-Japiassu (Paris, France), V. Codullo (Pavia, Italy), L. Cavagna (Pavia, Italy), V. Vertui (Pavia, Italy), S. Bozzini (Pavia, Italy), M. Morosini (Pavia, Italy), S. Castañeda (Madrid, Spain), E. Fattal (Paris, France), F. Meloni (Pavia, Italy)
| |
Late Breaking Abstract - Role of matrix metalloproteinase-2 and -9 in experimental lung fibrosis in mice
T. Bormann (Hannover, Germany), R. Maus (Hannover, Germany), J. Stolper (Hannover, Germany), C. Brandenberger (Hannover, Germany), T. Welte (Hannover, Germany), J. Gauldie (Hamilton, Canada), M. Kolb (Hamilton, Canada), U. Maus (Hannover, Germany)
| |
Discussion
| |